본문 바로가기

Data Plus(+)

All 807,818 Page 4,377/80,782

검색

Contents

No Journal_name Subject Date DOI Author
764058 JOURNAL FOR IMMUNOTHERAPY OF CANCER 406 Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: a phase II, single-arm, exploratory research 2021-11-01 10.1136/jitc-2021-sitc2021.406 Ma Jianqun, Zhang Jinfeng, Yang Yingnan, Zheng Dayong, Wang Xiaoyuan, Liang Hao, Zhang Luquan, Xin Yanzhong, Ling Xiaodong, Fang Chengyuan, Jiang Hao, Zheng Wei
764057 JOURNAL FOR IMMUNOTHERAPY OF CANCER 404 Initial biomarker and clinical data of a phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer 2021-11-01 10.1136/jitc-2021-sitc2021.404 Kim Richard, Barve Minal, Mamdani Hirva, Johnson Melissa, Lee Byung Ha, Ferrando-Martinez Sara, Chaney Marya, Fan Jean, Le NgocDiep, Naing Aung
764056 JOURNAL FOR IMMUNOTHERAPY OF CANCER 378 Efficacy, safety and ancillary analyses of pembrolizumab in combination with nintedanib for the treatment of patients with relapsed advanced mesothelioma 2021-11-01 10.1136/jitc-2021-sitc2021.378 Danlos Francois-Xavier, Baldini Capucine, Texier Matthieu, Varga Andreea, Mouraud Severine, Job Bastien, Letourneur Diane, Cassard Lydie, Bredel Delphine, Laghouati Salim, Adam Julien, Droin Nathalie, Parpaleix Aurelien, Chaput-Gras Nathalie, Rabeau Audrey, Zalcman Gerard, Planchard David, Massard Christophe, Soria Jean-Charles, Marabelle Aurelien
764055 JOURNAL FOR IMMUNOTHERAPY OF CANCER 375 Development of thrombospondin-1 as a clinical pharmacodynamic biomarker for VT1021, a first-in-class therapeutic agent that reprograms the tumor microenvironment 2021-11-01 10.1136/jitc-2021-sitc2021.375 Chen Jian, Crochiere Marsha, Vincent Melanie, Wang Suming, Fyfe Susanne, Li Wendy, Deng Simai, Watnick Randolph, Watnick Jing, Cieslewicz Michael
764054 JOURNAL FOR IMMUNOTHERAPY OF CANCER 374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors 2021-11-01 10.1136/jitc-2021-sitc2021.374 Tyan Kevin, Rahma Osama, Giobbie-Hurder Anita, Brohl Andrew, Bedard Philippe, Renouf Daniel, Sharon Elad, Streicher Howard, Hathaway Emma, Cunningham Rachel, Manos Michael, Severgnini Mariano, Rodig Scott, Stephen Hodi F
764053 JOURNAL FOR IMMUNOTHERAPY OF CANCER 373 Enhancement of TCR-engineered T-cells targeting MAGE-A4 antigen by co-expression of CD8α and inhibition of AKT signaling during ex vivo T-cell expansion 2021-11-01 10.1136/jitc-2021-sitc2021.373 Schmidt Emily, Mardilovich Katerina, Bath Natalie, Betts Gareth, Spinner William, Sun Kathryn, Donaldson Ian, McAlpine Cheryl, Luke Raymond, Navenot Jean-Marc, Sanderson Joseph, Bassett Phil, Evans Chris, Miller Karen, Lin Quan, Dudley Mark, Tipping Alex
764052 JOURNAL FOR IMMUNOTHERAPY OF CANCER 371 Analysis of changes in plasma cytokine levels in response to IL-12 therapy in three clinical trials 2021-11-01 10.1136/jitc-2021-sitc2021.371 Schwarz Emily, Benner Brooke, Yu Lianbo, Carson William
764051 JOURNAL FOR IMMUNOTHERAPY OF CANCER 368 Consistent pattern of immune activation induced by oncolytic adenovirus ONCOS-102 across diverse types of solid tumors 2021-11-01 10.1136/jitc-2021-sitc2021.368 Kuryk Lukasz, Moller Anne-Sophie, Kumar Sandeep, Shoushtari Alexander, Ares Luis Paz, Jaderberg Magnus, Wiklund Erik Digman, Levitsky Victor
764050 JOURNAL FOR IMMUNOTHERAPY OF CANCER 385 Identification and enrichment of neoantigen-reactive T cells to optimize adoptive cell transfer with tumor-infiltrating lymphocytes (TIL) 2021-11-01 10.1136/jitc-2021-sitc2021.385 Hall MacLean, Branthoover Holly, Beatty Matthew, Twumasi-Boateng Kwame, Bender Jim, Ceccarelli Jake, Langer TJ, Teer Jamie, Sarnaik Amod, Pilon-Thomas Shari
764049 JOURNAL FOR IMMUNOTHERAPY OF CANCER 907 Modulation of tumor immunogenicity by DNA methylation of immune synapse genes in cancers 2021-11-01 10.1136/jitc-2021-sitc2021.907 Hamaidi Imene, Berglund Anders, Mills Matthew, Putney Ryan, Mule James, Kim Sungjune